Gillis Steven

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Gillis Steven
CIK #0001229592
EDGAR Form CIK 2011 - 2025
3 [0001229592]
4 [0001229592]
Form 3/4/5 Subject 2011 - 2025
ARCH Venture Fund X, L.P.
ARCH Venture Fund X Overage, L.P.
ARCH Venture Partners X, LLC
Crandell Keith
Gillis Steven
ARCH Venture Partners X, L.P.
ARCH Venture Partners X Overage, L.P.
Burow Kristina
Prime Medicine, Inc.
Lyell Immunopharma, Inc.
ARCH Venture Partners XIII, LLC
Berns Paul L
Nelsen Robert
ARCH Venture Partners XIII, L.P.
ARCH Venture Fund XIII, L.P.
Metsera, Inc.
ARCH Venture Partners XII, LLC
ARCH Venture Fund XII, L.P.
ARCH Venture Partners XII, L.P.
Maze Therapeutics, Inc.
Rapport Therapeutics, Inc.
Boundless Bio, Inc.
Bybee Clinton
Sana Biotechnology, Inc.
Neumora Therapeutics, Inc.
DA32 Life Science Tech Acquisition Corp.
ARCH Venture Partners XI, L.P.
ARCH Venture Partners XI, LLC
ARCH Venture Fund XI, L.P.
VBI Vaccines Inc/BC
Q32 Bio Inc.
Codiak BioSciences, Inc.
Erasca, Inc.
Verve Therapeutics, Inc.
Pulmatrix, Inc.
VBI Vaccines Inc
Sienna Biopharmaceuticals, Inc.
ARCH Venture Partners VII, LLC
ARCH Venture Fund VII, L.P.
ARCH Venture Partners VII, L.P.
Phaserx Inc
bluebird bio, Inc.
Terms | Privacy | Guide
tony@aum13f.com